EBS
Emergent BioSolutions Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -7.0% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 77 | 0 | 32.10M | $268.98M | +5 | −5 |
| Q1 2026 | 79 | +5 | 31.51M | $261.75M | +9 | −4 |
| Q4 2025 | 74 | 0 | 30.66M | $378.98M | — | — |
| Q3 2025 | 18 | +2 | 16.19M | $142.77M | +2 | — |
| Q2 2025 | 13 | 0 | 14.86M | $94.78M | — | — |
| Q1 2025 | 10 | -1 | 7.86M | $38.21M | — | −1 |
| Q4 2024 | 11 | +1 | 7.58M | $72.46M | +1 | — |
| Q3 2024 | 9 | 0 | 6.09M | $50.89M | +1 | −1 |
| Q2 2024 | 9 | — | 4.41M | $30.11M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 4.36M | — | $27.82M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 4.36M | — | $27.82M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (pasivo) | 4.36M | — | $27.82M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 4.36M | — | $27.82M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 4.36M | — | $27.82M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 4.36M | — | $27.82M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 4.36M | — | $27.82M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | The Vanguard Group ✦ (pasivo) | 3.58M | — | $22.87M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | The Vanguard Group ✦ (pasivo) | 3.58M | — | $22.87M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (pasivo) | 3.58M | — | $22.87M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | State Street Global Advisors ✦ (pasivo) | 1.74M | +1.8% | $11.11M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Geode Capital Management ✦ (pasivo) | 1.28M | +108.9% | $8.16M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Geode Capital Management ✦ (pasivo) | 1.28M | +108.9% | $8.16M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Marshall Wace ✦ | 1.02M | -12.0% | $6.50M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | Marshall Wace ✦ | 1.02M | -12.0% | $6.50M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | Millennium Management ✦ | 755.43K | -69.8% | $4.82M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 689.65K | -9.3% | $4.40M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 411.37K | +51.1% | $2.62M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 411.37K | +51.1% | $2.62M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 353.67K | -10.9% | $2.26M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 281.50K | -4.5% | $1.80M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 281.50K | -4.5% | $1.80M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 23 | Wellington Management ✦ | 173.17K | +21.1% | $1.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Wellington Management ✦ | 173.17K | +21.1% | $1.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Wellington Management ✦ | 173.17K | +21.1% | $1.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Fidelity (FMR) ✦ | 168.52K | — | $1.08M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Fidelity (FMR) ✦ | 168.52K | — | $1.08M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | T. Rowe Price ✦ | 38.83K | +229.0% | $248,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 187 tenedores, 43.00M acciones, $335.12M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.